» Articles » PMID: 34320133

Indeterminate Form of Chagas Disease: Historical, Conceptual, Clinical, and Prognostic Aspects

Overview
Specialty Tropical Medicine
Date 2021 Jul 28
PMID 34320133
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Chagas disease (CD) remains a serious endemic disease in Latin America and a major public health problem. Because of globalization, the disease has spread to non-endemic areas in the northern hemisphere. In the chronic phase of the disease, most patients present with the indeterminate form (IF), characterized by positive serology for Trypanosoma cruzi, absence of clinical findings, and normal findings in electrocardiogram (ECG). IF was not recognized as a clinical entity until decades after the discovery of the disease, and only in the 1940-50s, it was categorized as a form of CD, and its conceptual definition was ratified in the 1980s. Children, adolescents, and young adults with the IF benefit from etiological treatment and tend to have less progression to heart disease in the long term than the untreated ones. IF patients have an essentially benign clinical condition, and their prognosis can be compared to that of healthy individuals with normal ECG findings. Currently, because of aging, patients with the IF have comorbidities that require attention in health services.

Citing Articles

Multidisciplinary nursing care in chronic Chagas disease: a scoping review.

Silva A, Leony L, Daltro R, Santos E, Freitas N, de Carvalho Medrado Vasconcelos L BMC Nurs. 2025; 24(1):50.

PMID: 39810196 PMC: 11734354. DOI: 10.1186/s12912-024-02621-5.


Influence of angiotensin II type 1 receptors and angiotensin-converting enzyme I/D gene polymorphisms on the progression of Chagas' heart disease in a Brazilian cohort: Impact of therapy on clinical outcomes.

Protasio da Silva T, Alvarado-Arnez L, Batista A, Alves S, Melo G, Carrazzone C PLoS Negl Trop Dis. 2024; 18(11):e0012703.

PMID: 39591456 PMC: 11630595. DOI: 10.1371/journal.pntd.0012703.


Chagas Disease: A Silent Threat for Dogs and Humans.

Duraes-Oliveira J, Palma-Marques J, Moreno C, Rodrigues A, Monteiro M, Alexandre-Pires G Int J Mol Sci. 2024; 25(7).

PMID: 38612650 PMC: 11011309. DOI: 10.3390/ijms25073840.


Seroepidemiological Survey of Chronic Chagas Disease in a Rural Community in Southern Bahia, Brazil, Using Recombinant Chimeric Antigens.

Soares N, Barreto N, Farias M, Oliveira C, Araujo W, de Souza J Pathogens. 2023; 12(10).

PMID: 37887738 PMC: 10609786. DOI: 10.3390/pathogens12101222.


Clinical Characteristics and Outcomes of Chagas Disease in the United States: A Multicenter Retrospective Analysis.

Henao-Martinez A, Olivo-Freites C, Higuita N, Ferraz C, Franco-Paredes C, Tuells J Am J Trop Med Hyg. 2023; 109(5):1006-1011.

PMID: 37696508 PMC: 10622470. DOI: 10.4269/ajtmh.23-0361.


References
1.
Macedo V . Indeterminate form of Chagas disease. Mem Inst Oswaldo Cruz. 2000; 94 Suppl 1:311-6. DOI: 10.1590/s0074-02761999000700059. View

2.
Andrade Z, Andrade S, Sadigursky M, Wenthold Jr R, Hilbert S, Ferrans V . The indeterminate phase of Chagas' disease: ultrastructural characterization of cardiac changes in the canine model. Am J Trop Med Hyg. 1997; 57(3):328-36. DOI: 10.4269/ajtmh.1997.57.328. View

3.
Frade-Barros A, Ianni B, Cabantous S, Pissetti C, Saba B, Lin-Wang H . Polymorphisms in Genes Affecting Interferon-γ Production and Th1 T Cell Differentiation Are Associated With Progression to Chagas Disease Cardiomyopathy. Front Immunol. 2020; 11:1386. PMC: 7358543. DOI: 10.3389/fimmu.2020.01386. View

4.
Biolo A, Ribeiro A, Clausell N . Chagas cardiomyopathy--where do we stand after a hundred years?. Prog Cardiovasc Dis. 2010; 52(4):300-16. DOI: 10.1016/j.pcad.2009.11.008. View

5.
Vazquez C, Garcia-Vazquez E, Carrilero B, Simon M, Franco F, Iborra M . Pregnancy and Chagas Disease: Benznidazole's Impact on Pregnancy and Newborns: A Report of Four Cases. Am J Trop Med Hyg. 2020; 102(5):1075-1077. PMC: 7204601. DOI: 10.4269/ajtmh.19-0348. View